Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Front Immunol ; 14: 1212745, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37753077

RESUMEN

Aim: This study aimed to evaluate if physical activity is associated with systemic and cellular immunometabolic responses, in young adults after mild-to-moderate COVID-19 infection. Methods: Mild- to- moderate post-COVID-19 patients (70.50 ± 43.10 days of diagnosis; age: 29.4 (21.9- 34.9) years; BMI: 25.5 ± 4.3 kg m2 n = 20) and healthy age-matched controls (age: 29.3 (21.2 - 32.6) years; BMI: 25.4 ± 4.7 kg m2; n = 20) were evaluated. Physical activity levels (PAL), body composition, dietary habits, muscular and pulmonary function, mental health, sleep quality, metabolic parameters, immune phenotypic characterization, stimulated whole blood and PBMC culture (cytokine production), mRNA, and mitochondrial respiration in PBMCs were evaluated. Results: The post-COVID-19 group exhibited lower levels of moderate to vigorous physical activity (MVPA) (p = 0.038); therefore, all study comparisons were performed with adjustment for MVPA. Post-COVID-19 impacted the pulmonary function (FEV1, FEV1%pred, FVC, and FVC %pred) compared with the control (p adjusted by MVPA (p adj) <0.05). Post-COVID-19 exhibited lower levels of serum IL-6 (p adj <0.01), whereas it showed higher serum IL-10, triglyceride, leptin, IgG, ACE activity, TNFRSF1A, and PGE2 (p adj <0.05) levels compared with controls. Post-COVID-19 presented a lower percentage of Treg cells (p adj = 0.03) and altered markers of lymphocyte activation and exhaustion (lower CD28 expression in CD8+ T cells (p adj = 0.014), whereas CD4+T cells showed higher PD1 expression (p adj = 0.037)) compared with the control group. Finally, post- COVID-19 presented an increased LPS-stimulated whole- blood IL-10 concentration (p adj <0.01). When exploring mitochondrial respiration and gene expression in PBMCs, we observed a higher LEAK state value (p adj <0.01), lower OXPHOS activity (complex I) (p adj = 0.04), and expression of the Rev-Erb-α clock mRNA after LPS stimulation in the post-COVID-19 patients than in the control (p adj <0.01). Mainly, PAL was associated with changes in IL-10, triglyceride, and leptin levels in the plasma of post-COVID-19 patients. PAL was also associated with modulation of the peripheral frequency of Treg cells and the expression of PD-1 in CD8+ T cells, although it abrogated the statistical effect in the analysis of TNF-α and IL-6 production by LPS- and PMA-stimulated PBMC of post-COVID-19 patients. Conclusion: Young adults after mild-to-moderate SARS-CoV-2 infection appeared to have lower physical activity levels, which can be associated with clinical and immunometabolic responses in a complex manner.


Asunto(s)
COVID-19 , Activación de Linfocitos , Adulto Joven , Humanos , Adulto , Linfocitos T CD8-positivos , Interleucina-10 , Interleucina-6 , Leptina , Leucocitos Mononucleares , Lipopolisacáridos , SARS-CoV-2
2.
Fisioter. Mov. (Online) ; 30(4): 831-838, Oct.-Dec. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-892018

RESUMEN

Abstract Introduction: Recent studies have pointing creatine supplementation as a promising therapeutic alterna- tive in several diseases, especially myopathies and neurodegenerative disorder. Objective: elucidate the role of creatine supplementation on deleterious effect caused by limb immobilization in humans and rats. Methods: Analyzed articles were searched by three online databases, PubMed, SportDicus e Scielo. After a review and analysis, the studies were included in this review articles on effect of creatine supplementation on skeletal muscle in humans and rat, before, during and after a period of limb immobilization. Results: Studies analyzed demonstrated positive points in use of creatine supplementation as a therapeutic tool to mitigating the deleterious effects of limb immobilization, in humans and rat. Conclusion: The dataset of this literature review allows us to conclude that creatine supplementation may reduce muscle loss and/or assist in the recovery of muscle atrophy caused by immobilization and disuse in rats and humans. Also, we note that further research with better methodological rigor is needed to clarify the mechanisms by which creatine support the recovery of muscle atrophy. Moreover, these effects are positive and promising in the field of muscle rehabilitation, especially after member's immobilization.


Resumo Introdução: Estudos recentes apontam a suplementação de creatina como promissora alternativa terapêuti- ca em desordens de diversos tipos, especialmente miopatias e desordens neurodegenerativas. Objetivo: Essa revisão tem o objetivo de elucidar o papel da creatina sobre a perda da massa muscular causada pela imobili- zação de membros em seres humanos e ratos. Métodos: Os artigos analisados foram buscados em três bases de dados on-line, PubMed, SportDiscus e Scielo. Após análise dos estudos, foram incluídos na presente revisão os efeitos da suplementação de creatina na musculatura esquelética, envolvendo seres humanos e roedores, antes, durante e depois de um período de imobilização e desuso. Resultados: Os estudos analisados apresentaram pontos positivos sobre a utilização de creatina, sobretudo quando combinado com outro recurso terapêutico, atenuando a atrofia muscular causada pela imobilização de membros. Conclusão: Em suma, o conjunto de dados ainda que limitantes apresentado por essa revisão de literatura nos permite concluir que a suplemen- tação com creatina é capaz de amenizar a perda de massa muscular e/ou auxiliar na recuperação da atrofia muscular causada pela imobilização e desuso em ratos e humanos. Ainda, salientamos que mais investigações com melhor rigor metodológico são necessárias para o esclarecimento sobre os mecanismos pelo qual a creati- na favorece a recuperação da atrofia muscular. Alem disso, esses efeitos são positivos e promissores na área da reabilitação muscular, especialmente após a imobilização de membros.


Asunto(s)
Humanos , Animales , Atrofia Muscular , Creatina , Inmovilización , Músculo Esquelético , Enfermedades Musculares
3.
Appl Physiol Nutr Metab ; 42(9): 916-923, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28475846

RESUMEN

The aim of this study was to investigate the effects of resistance exercise training (RET) on oxidative stress, systemic inflammatory markers, and muscle wasting in Walker-256 tumor-bearing rats. Male (Wistar) rats were divided into 4 groups: sedentary controls (n = 9), tumor-bearing (n = 9), exercised (n = 9), and tumor-bearing exercised (n = 10). Exercised and tumor-bearing exercised rats were exposed to resistance exercise of climbing a ladder apparatus with weights tied to their tails for 6 weeks. The physical activity of control and tumor-bearing rats was confined to the space of the cage. After this period, tumor-bearing and tumor-bearing exercised animals were inoculated subcutaneously with Walker-256 tumor cells (11.0 × 107 cells in 0.5 mL of phosphate-buffered saline) while control and exercised rats were injected with vehicle. Following inoculation, rats maintained resistance exercise training (exercised and tumor-bearing exercised) or sedentary behavior (control and tumor-bearing) for 12 more days, after which they were euthanized. Results showed muscle wasting in the tumor-bearing group, with body weight loss, increased systemic leukocytes, and inflammatory interleukins as well as muscular oxidative stress and reduced mTOR signaling. In contrast, RET in the tumor-bearing exercised group was able to mitigate the reduced body weight and muscle wasting with the attenuation of muscle oxidative stress and systemic inflammatory markers. RET also prevented loss of muscle strength associated with tumor development. RET, however, did not prevent the muscle proteolysis signaling via FBXO32 gene messenger RNA expression in the tumor-bearing group. In conclusion, RET performed prior tumor implantation prevents cachexia development by attenuating tumor-induced systemic pro-inflammatory condition with muscle oxidative stress and muscle damage.


Asunto(s)
Caquexia/prevención & control , Carcinoma 256 de Walker/terapia , Leucocitosis/prevención & control , Debilidad Muscular/prevención & control , Músculo Esquelético/fisiopatología , Estrés Oxidativo , Condicionamiento Físico Animal , Animales , Biomarcadores/sangre , Biomarcadores/metabolismo , Caquexia/etiología , Caquexia/inmunología , Carcinoma 256 de Walker/metabolismo , Carcinoma 256 de Walker/patología , Carcinoma 256 de Walker/fisiopatología , Citocinas/sangre , Regulación Neoplásica de la Expresión Génica , Mediadores de Inflamación/sangre , Leucocitosis/etiología , Leucocitosis/inmunología , Masculino , Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Debilidad Muscular/etiología , Debilidad Muscular/inmunología , Músculo Esquelético/inmunología , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Distribución Aleatoria , Ratas Wistar , Proteínas Ligasas SKP Cullina F-box/genética , Proteínas Ligasas SKP Cullina F-box/metabolismo , Serina-Treonina Quinasas TOR/genética , Serina-Treonina Quinasas TOR/metabolismo , Carga Tumoral , Aumento de Peso , Pérdida de Peso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA